Novartis Signs USD 1.9 Billion Cancer Drug Discovery Pact with Antares Therapeutics sheeba farhat26 Jun 2026 4:21 PM ISTBengaluru: Antares Therapeutics said on Wednesday it entered a collaboration with Novartis that could be worth up to about USD 1.9 billion, aiming to...
Mankind Pharma Appoints Nilesh Kulkarni as Group HR Head in Leadership Reshuffle Parthika Patel12 Jun 2026 11:43 PM ISTNew Delhi: Mankind Pharma has appointed Nilesh Kulkarni as the Head of Human Resource Functions for the Mankind Pharma Group as part of a strategic...
Alembic Secures USFDA Approval for Gilenya Generic Parthika Patel27 April 2026 12:15 PM ISTVadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Fingolimod Capsules,...
Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline sheeba farhat29 March 2026 11:00 AM ISTLondon: Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a deal worth up to USD 2 billion, the...
Servier to Buy Day One Biopharma for USD 2.5B, Adds USFDA-Approved Brain Tumor Drug Ojemda sheeba farhat8 March 2026 11:00 AM ISTBengaluru: French drugmaker Servier said on Friday it would buy U.S.-based Day One Biopharmaceuticals for about USD 2.5 billion, expanding its brain...
Aurobindo's Eugia Arm Secures USFDA Nod for Transplant Drug Everolimus Parthika Patel26 Feb 2026 9:27 PM ISTNew Delhi: Aurobindo Pharma Limited announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from...
Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026 sheeba farhat6 Feb 2026 11:30 AM ISTNew Delhi: Novartis forecast its first annual drop in operating profit in a decade on Wednesday, even as it indicated that long ‌term, the company...
AI Reshapes Drug Development Workflows, But Breakthrough Molecules Still Elusive sheeba farhat27 Jan 2026 2:05 PM ISTDrug companies have announced a slew of deals for tools to unleash the promise of AI, seen as the biggest technological upheaval since the internet,...
Novartis names Sreeman Balineni as new Executive Director Ruchika Sharma30 Nov 2025 4:00 PM ISTNovartis has appointed Sreeman Balineni as its new Executive Director.Before joining Novartis, he served as Senior Director, GCC India Head-...
USFDA greenlights Novartis gene replacement therapy for spinal muscular atrophy Ruchika Sharma25 Nov 2025 11:30 AM ISTBasel: Novartis has received approval from the US Food and Drug Administration (FDA) for Itvisma (onasemnogene abeparvovec-brve) for the...
Novartis declares positive results from phase III study for new malaria treatment Ruchika Sharma17 Nov 2025 2:30 PM ISTBasel: Novartis has announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156 (ganaplacide/lumefantrine, or...
Novartis opens new radioligand therapy manufacturing facility in California Ruchika Sharma11 Nov 2025 10:30 AM ISTBasel: Novartis, a global medicines company, has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in...
